Y. Togashi

发表

Combination tumor‐immunotherapy with recombinant tumor necrosis factor and recombinant interleukin 2 in mice

Y. Hashimoto, T. Nishimura, S. Ohta, 1987, International journal of cancer.

Rat macrophage activation after treatment with the bleomycin group of antitumour antibiotics in vivo

M. Micallef, Y. Togashi, M. Hosokawa, 2005, Cancer Immunology, Immunotherapy.

An efficient method to prepare T cell receptor gene‐transduced cytotoxic T lymphocytes type 1 applicable to tumor gene cell‐therapy

Kazuhiko Yamamoto, T. Kitamura, Y. Togashi, 2003, Cancer science.

Combination immunotherapy with radiation and CpG‐based tumor vaccination for the eradication of radio‐ and immuno‐resistant lung carcinoma cells

H. Shirato, Y. Togashi, T. Omatsu, 2009, Cancer science.

Identification of novel helper epitopes of MAGE-A4 tumour antigen: useful tool for the propagation of Th1 cells

Y. Togashi, K. Chamoto, D. Wakita, 2009, British Journal of Cancer.

Essential role of Toll-like receptors for dendritic cell and NK1.1(+) cell-dependent activation of type 1 immunity by Lactobacillus pentosus strain S-PT84.

Tomomi Sato, Y. Togashi, T. Izumo, 2008, Immunology letters.

Generation of leukemia-specific T-helper type 1 cells applicable to human leukemia cell-therapy.

H. Tagami, S. Aiba, M. Imamura, 2004, Immunology letters.

Critical role of the Th1/Tc1 circuit for the generation of tumor‐specific CTL during tumor eradication in vivo by Th1‐cell therapy

Y. Togashi, J. Matsuzaki, K. Chamoto, 2003, Cancer science.

Differential regulation of VLA-2 expression on Th1 and Th2 cells: a novel marker for the classification of Th subsets.

Y. Togashi, K. Chamoto, T. Tsuji, 2003, International immunology.

unimmunized mice as novel immunomodulator of IFN-g-dependent type 1 immunity

Y. Togashi, S. Nishimura, D. Wakita, 2007 .

AsialoGM1+CD8+ central memory-type T cells in unimmunized mice as novel immunomodulator of IFN-gamma-dependent type 1 immunity.

Y. Togashi, S. Nishimura, D. Wakita, 2007, International immunology.

IFN-gamma-dependent type 1 immunity is crucial for immunosurveillance against squamous cell carcinoma in a novel mouse carcinogenesis model.

Y. Togashi, H. Shiku, H. Nishikawa, 2009, Carcinogenesis.

Natural killer T cells from interleukin‐4‐deficient mice are defective in early interferon‐γ production in response to α‐galactosylceramide

Y. Iwakura, Y. Togashi, K. Chamoto, 2007 .

T Cell Receptor‐independent Cell‐mediated Cytotoxicity by Nude Mouse Lymphokine‐activated Killer Cells

Y. Hashimoto, Y. Togashi, K. Okumura, 1991, Japanese journal of cancer research : Gann.

Unexpected role of TNF-α in graft versus host reaction (GVHR) : donor-derived TNF-α suppresses GVHR via inhibition of IFN-γ-dependent donor type-1 immunity

T. Koike, Y. Togashi, Satoshi Yamamoto, 2004 .

1-Dependent Airway Inflammation in Pulmonary Neutrophilia During Th Type A Critical Role for Mouse CXC Chemokine ( s )

Kazuhito Watanabe, K. Matsushima, S. Nakaike, 2001 .

Increased Production of Cytotoxic Macrophage Progenitors by Lactobacillus casei in Mice

R. Suzuki, Y. Togashi, K. Kumagai, 1989, Journal of leukocyte biology.

Local radiation therapy inhibits tumor growth through the generation of tumor-specific CTL: its potentiation by combination with Th1 cell therapy.

H. Shirato, Y. Togashi, K. Chamoto, 2010, Cancer research.

Interleukin‐12‐responding asialoGM1+CD8+ central memory‐type T cells as precursor cells for interferon‐γ‐producing killer T cells

Y. Togashi, S. Nishimura, D. Wakita, 2006, Cancer science.

[Development of DNA array filter useful for the analysis of Th1/Th2 balance].

Y. Togashi, T. Koda, T. Nishimura, 2005, Nihon Rinsho Men'eki Gakkai kaishi = Japanese journal of clinical immunology.

Transforming growth factor beta 1 (TGF-beta 1) produced in tumour tissue after chemotherapy acts as a lymphokine-activated killer attractant.

Y. Togashi, M. Kobayashi, Y. Kuramitsu, 1996, British Journal of Cancer.

Th1 Cytokine-Conditioned Bone Marrow-Derived Dendritic Cells Can Bypass the Requirement for Th Functions During the Generation of CD8+ CTL1

Y. Iwakura, Y. Togashi, K. Chamoto, 2001, The Journal of Immunology.

CTL + Generation of CD 8 the Requirement for Th Functions During the Marrow-Derived Dendritic Cells Can Bypass Th 1 Cytokine-Conditioned Bone

Y. Iwakura, Y. Togashi, K. Chamoto, 2001 .

Identification of novel helper epitope peptides of Survivin cancer-associated antigen applicable to developing helper/killer-hybrid epitope long peptide cancer vaccine.

K. Okuno, Y. Togashi, H. Kitamura, 2014, Immunology letters.

First clinical trial of cancer vaccine therapy with artificially synthesized helper/ killer‐hybrid epitope long peptide of MAGE‐A4 cancer antigen

S. Todo, Y. Togashi, D. Wakita, 2012, Cancer science.

Augmentation of the therapeutic efficacy of adoptive tumor immunotherapy by in vivo administration of slowly released recombinant interleukin 2

Yuji Togashi, Takashi Nishimura, Y. Hashimoto, 2004, Cancer Immunology, Immunotherapy.

Development of a functional cDNA array for evaluation of the Th1/Th2 balance.

Y. Shinohara, H. Ikeda, Y. Togashi, 2005, Immunology letters.

Identification of a meiosis-specific protein, MEIOB, as a novel cancer/testis antigen and its augmented expression in demethylated cancer cells.

Y. Togashi, Yasuo Shiohama, H. Kitamura, 2014, Immunology letters.

Potentiation of Tumor Eradication by Adoptive Immunotherapy with T-cell Receptor Gene-Transduced T-Helper Type 1 Cells

T. Kitamura, Y. Togashi, H. Abe, 2004, Cancer Research.

Artificially synthesized helper/killer-hybrid epitope long peptide (H/K-HELP): preparation and immunological analysis of vaccine efficacy.

Y. Togashi, D. Wakita, H. Kitamura, 2015, Immunology letters.

Augmented accumulation of transferred lymphokine-activated killer (LAK) cells at murine tumor sites through production of LAK-attractant facilitated by chemotherapy.

M. Micallef, Y. Togashi, Y. Kuramitsu, 1992, The Tohoku journal of experimental medicine.

NKT cells act as regulatory cells rather than killer cells during activation of NK cell-mediated cytotoxicity by alpha-galactosylceramide in vivo.

H. Ikeda, Y. Togashi, J. Matsuzaki, 2004, Immunology letters.

A Critical Role for Mouse CXC Chemokine(s) in Pulmonary Neutrophilia During Th Type 1-Dependent Airway Inflammation1

Kazuhito Watanabe, K. Matsushima, S. Nakaike, 2001, The Journal of Immunology.